데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
기본 정보
- CAS
330784-47-9- 표준 SMILES
COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl- InChIKey
WEAJZXNPAWBCOA-INIZCTEOSA-N- 분자식
- C23H26ClN7O3
- 평균 분자량
- 483.96 g/mol
- 단동위원소 질량
- 483.17856537
이름 및 식별자
- 우선 이름
- Avanafil
- IUPAC
- 4-{[(3-Chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-[(pyrimidin-2-yl)methyl]pyrimidine-5-carboxamide
- 영어명
- Avanafil
- 분자식
- C23H26ClN7O3
- 분자량
- 483.95
이름 및 동의어
Stendravanafilavanfil4-((3-chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide(S)-4-((3-Chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMideU 53U-53D03217AVANAFEAvanafi
데이터베이스 식별자
- CAS
330784-47-9- PubChem CID
- 9869929
- DTXSID
DTXSID50186727- ChEMBL
CHEMBL1963681- ChEBI
CHEBI:66876- UNII
- DR5S136IVO
- EC Number
- 841-424-3
- Nikkaji
- J2.782.076J
물성
물리화학적 성질
- 녹는점
- 150 · 150-152°C
- 밀도
- 1.372 · 1.372
- 저장 조건
- -20 °C · Sealed in dry,Store in freezer, under -20°C
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열)
- 물리적 상태
- 고체
- 산도 계수 (pKa)
- 11.84 · 11.84±0.46(Predicted)
- 색상
- 흰색에서 황백색까지
- InChIKey
- WEAJZXNPAWBCOA-INIZCTEOSA-N
- SMILES
- C1(N2CCC[C@H]2CO)=NC=C(C(NCC2=NC=CC=N2)=O)C(NCC2=CC=C(OC)C(Cl)=C2)=N1
화학적 성질
White Solid
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
안전 데이터
- wgk
- WGK 3
- HS 번호
- 29339900
- 스토리지 클래스
- 11 - Combustible Solids
화학 및 산업
응용 분야
개요Avanafil (Zepeed) was approved by the Korean Health Ministry for the treatment of erectile dysfunction (ED) in August 2011. Avanafil is a highly selective type 5 phosphodiesterase (PDE5) inhibitor. Avanafil is reported to be the most selective PDE5 inhibitor on the market. The onset of Tmax and half-life also varies among the marketed PDE5 inhibitors. Sildenafil has a Tmax at 1 h and a half-life of 3–5 h. Vardenafil is somewhat similar with a Tmax of 0.6 h and a half-life of 4–6 h. Tadalafil has the longest half-life among the marketed drugs with a half-life of 17 h. Avanafil has a fast onset of action reaching Tmax in 0.6 h with a half-life of 1.2 h. A synthesis of avanafil (TA-1790) is described in the patent literature. The main elimination route of avanafil is through the bile and feces. Avanafil was also found to be reabsorbed through enterohepatic recirculation.
용도Avanafil is a highly selective PDE5 inhibitor with IC50 of 1 nM.
상·하류 제품 정보
상류 원료
관련 반응
2건
화합물 노트
불러오는 중…